Size-dependent biodistribution of carbon nanohorns in vivo

详细信息    查看全文

• 作者：Minfang Zhang^a ; ^{m-zhang@aist.go.jp} ; Takashi Yamaguchi^b ; Sumio Iijima^a ; ^b ; ^c ; Masako Yudasaka^a ; ^{m-yudasaka@aist.go.jp}
• 关键词：Nanoparticle ; Carbon nanohorns ; Biodistribution ; Biokinetics
• 刊名：Nanomedicine: Nanotechnology, Biology and Medicine
• 出版年：2013
• 出版时间：July, 2013
• 年：2013
• 卷：9
• 期：5
• 页码：657-664
• 全文大小：2452 K

文摘

Carbon nanotubules, such as nanotubes and nanohorns, are potentially useful as drug delivery or hyperthermia agents for cancer therapy. However, the biokinetics of variously sized nanocarbons are important for their medical application and risk assessment. To examine the time course of the biodistribution of carbon nanohorns (CNHs) in mice, CNH aggregates of 100 nm (L-CNHs) or CNHs of 30-50 nm (S-CNHs) were dispersed with lipid polyethylene glycol and administered to mice through tail vein injection. Histological observation revealed that S-CNHs accumulated more slowly than did L-CNHs in the liver and spleen. The accumulation of L- and S-CNHs in spleen reached saturation within 1 and 48 h, respectively, and the accumulation in liver reached saturation within 48 h and > 7 days, respectively. CNHs did not accumulate appreciably in the lung, skin, or kidney. Histologic, hematologic, and immunologic (IL-6, TNF-¦Á, and IFN-¦Ã) tests did not reveal obvious toxicologic lesions at any time point.

From the Clinical Editor

In this study the biodistribution and accumulation characteristics of small and large carbon nanohorns were characterized in mice. Data demonstrate slower accumulation of small carbon nanohorns in liver and spleen, no accumulation in skin, lung, or kidney, and no obvious hematologic or immunologic toxicity.